Why Getting Hazard Classification Wrong Is More Expensive Than You Think

In many organisations, hazard classification in Safety Data Sheets (SDS) is often treated as a routine compliance activity — simply another requirement to complete during product launches or updates. However, with evolving EU CLP regulations and the addition of new hazard classes such as endocrine disruptors (ED), PBT, and PMT, this approach is becoming increasingly risky.

Incorrect hazard classification is no longer just a technical issue limited to SDS Section 2 (Hazard Identification). It can create widespread consequences across regulatory compliance, supply chain operations, market access, and overall business performance.

What’s Changing in SDS Compliance Requirements?

Recent updates to the EU CLP framework have introduced four new mandatory hazard classes:

• Endocrine Disruptors (Human Health)
• Endocrine Disruptors (Environment)
• PBT / vPvB (Persistent, Bioaccumulative, Toxic)
• PMT / vPvM (Persistent, Mobile, Toxic)

These classifications are far more complex than traditional hazard assessments. Instead of relying solely on threshold-based calculations, they require advanced scientific evaluation methods, including:

• Weight of Evidence (WoE) approaches
• Scientific literature and REACH dossier reviews
• In silico tools and QSAR models
• Read-across data from similar substances

As classification requirements become more sophisticated, the risk — and impact — of incorrect classification increases significantly.

The Real Cost of Incorrect Hazard Classification

Regulatory Non-Compliance and Penalties

With important CLP deadlines approaching in May 2025, May 2026, November 2026, and May 2028, inaccurate classifications can lead to:

• Non-compliant SDSs and labels
• Failed inspections and audits
• Product recalls, fines, or enforcement actions

Regulators are increasingly focusing on the scientific reliability of classification decisions, not just the documentation itself.

Market Access Challenges

A misclassified substance or mixture can:

• Delay or restrict access to EU markets
• Trigger re-submissions such as UFI/PCN notifications
• Result in product reformulation or withdrawal

Incorrect hazard communication can also impact customer confidence and downstream compliance obligations.

Supply Chain Disruptions

Many organisations still depend on outdated supplier information, which can result in:

• Inconsistent classifications across the supply chain
• Conflicting SDS versions
• Increased liability for suppliers, importers, and distributors

A single upstream classification error can affect multiple products and business partners downstream.

Operational and Financial Impact

What may begin as a small classification issue can quickly escalate into significant operational challenges, including:

• Revisions to SDS Sections 2, 3, 11, and 12
• Label redesign and reprinting
• Additional testing and expert evaluations
• Resource strain and project delays

In many cases, the cost of correcting classification errors is far greater than the investment required to ensure accuracy from the beginning.

Strategic Business Risks

Incorrect hazard classification can also influence long-term business decisions and outcomes, such as:

• Product portfolio sustainability
• Reformulation and innovation strategies
• ESG and sustainability commitments
• Brand reputation in highly regulated markets

In some cases, products may become commercially unviable due to persistence or endocrine disruption concerns.

Common Areas Where Errors Occur

The most common causes of classification errors include:

• Outdated or incomplete data sources
• Limited Weight of Evidence-based evaluations
• Over-reliance on legacy classifications
• Inconsistent updates across critical SDS sections, including:
  • Section 2: Hazard Identification
  • Section 3: Composition
  • Section 11: Toxicological Information
  • Section 12: Ecological Information

Why This Issue Is Becoming More Critical

This is more than a regulatory update — it represents a major shift in how chemical risks are assessed and communicated.

Unlike traditional hazard classifications, the new hazard classes:

• Focus on long-term and systemic effects
• Require multidisciplinary scientific expertise
• Demand continuous monitoring of scientific and regulatory developments

With compliance deadlines approaching rapidly, particularly the May 2026 deadline for mixtures, organisations that delay action may face increased operational, regulatory, and commercial risks.

The Smarter Approach: Prevention Over Correction

To minimise the risks and costs associated with misclassification, organisations should:

• Conduct early gap assessments across product portfolios
• Validate supplier data and align classifications
• Implement robust Weight of Evidence evaluation frameworks
• Proactively update SDS and labeling systems
• Continuously monitor evolving regulatory requirements

Taking proactive action early is no longer just good compliance practice — it is a strategic business decision.

Conclusion

Incorrect chemical hazard classification is not simply a technical error. It is a business risk multiplier that can affect compliance, operations, reputation, and market continuity.

As CLP requirements continue to evolve, organisations must ask themselves:

“Will our classifications remain compliant tomorrow?”

Avoid costly misclassification risks by ensuring your SDS hazard classifications align with evolving CLP requirements and GHS classification criteria before regulatory deadlines force reactive corrections.

Stay compliant and prepared with expert-led SDS and CLP compliance support from Freyr.